Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IVVD Invivyd > Detailed Quotes

IVVD Invivyd

Watchlist
2.480
+0.090+3.77%
Close  01/27 16:00 ET
2.470
-0.010-0.40%
Post Mkt Price 01/27 17:56 ET
High
2.680
Open
2.350
Turnover
828.96K
Low
2.350
Pre Close
2.390
Volume
328.66K
Market Cap
270.28M
P/E(TTM)
Loss
52wk High
12.110
Shares
108.98M
P/E(Static)
Loss
52wk Low
1.420
Float Cap
132.70M
Bid/Ask %
66.67%
Historical High
78.820
Shs Float
53.51M
Volume Ratio
0.98
Historical Low
1.420
Dividend TTM
--
Div Yield TTM
--
P/B
0.72
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.61%
Amplitude
13.81%
Avg Price
2.522
Lot Size
1
Float Cap
132.70M
Bid/Ask %
66.67%
Historical High
78.820
Shs Float
53.51M
Volume Ratio
0.98
Historical Low
1.420
Dividend TTM
--
P/B
0.72
Dividend LFY
--
Turnover Ratio
0.61%
Amplitude
13.81%
Avg Price
2.522
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Invivyd, Inc.(formerly Adagio Therapeutics, Inc.) engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers, ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren Russo and Laura Walker on June 3, 2020 and is headquartered in Waltham, MA.
CEO: Mr. David Hering
Market: NASDAQ
Listing Date: 08/06/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist